The Austrian Society for Lung Diseases and Tuberculosis: Consensus on the management of chronic obstructive pulmonary disease (COPD): Revised version 2004;Österreichische Gesellschaft für Lungenerkrankungen und Tuberkulose: Konsensus zum management der chronisch obstruktiven lungenerkrankungen (COPD) Revidierte fassung 2004

Wiener Klinische Wochenschrift

Volumn 116, Issue 7-8, 2004, Pages 268-278

  Lutz H Block, ^a   Burghuber, Otto C ^b,c   Hart, Sylvia ^b,c,e   Zwick, Hartmut ^d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b I Interne Lungenabteilung   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d GENERAL HOSPITAL LINZ   (Austria)

^e 1 Interne Lungenabteilung   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; GLUCOCORTICOID; IMMUNOMODULATING AGENT; SALMETEROL; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ANAMNESIS; AUSTRIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; HUMAN; INCIDENCE; INFLUENZA VACCINATION; LUNG FUNCTION TEST; MEDICAL SOCIETY; PATHOGENESIS; PHYSICAL EXAMINATION; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; ARTICLE; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; EVIDENCE BASED MEDICINE; THORAX RADIOGRAPHY; TIME;

DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOGRAPHY, THORACIC; RESPIRATORY FUNCTION TESTS; RISK FACTORS; TIME FACTORS;

EID: 2642546683     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03041059     Document Type: Review

References (23)

1. Hurd S (2000) The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 117 [Suppl 2]: 1S-4S
2. Mannino DM (2002) COPD: epidemiology, prevalence, morbidity and mortality, a disease heterogeneity. Chest 121 [Suppl 5]: 121S-126S
3. GOLD Executive Summary (2003) Global strategy for the diagnosis, management and prevention of COPD, published online: www.goldcopd.com
4. Russi EW, et al (2002) Management of chronic obstructive pulmonary disease: the Swiss guidelines. Swiss Med Wkly 132: 67-78 (www.smw.ch)
5. Anthonisen NR, Manfreda J, Warren CP (1987) Antibiotic therapy in exacerbations of COPD. Ann Intern Med 106: 196-204
6. Gillissen et al (2003) Management der akuten Exacerbation der chronisch obstruktiven Lungenerkrankung. Dtsch Med Wochenschr 128: 1721-1727
7. Worth H et al (2000) Leitlinie der Deutschen Atemwegs-Liga und der Deutschen Gesellschaft für Pneumologie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie 56: 704-738
8. Rodriguez-Roisin R (2000) Toward a consensus definition for COPD exacerbations. Chest 117: 398S-401S
9. McCrory DC, Brown C, Gelfand SE, Bach PB (2002) Management of acute exacerbations of COPD. Chest 119: 1190-1209
10. MacNee W, Calverley PMA (2003) Chronic obstructive pulmonary disease, review series 7: management of COPD. Thorax 58: 261-265
11. Rodriguez-Roisin R, Lloyd-Owen S, Wedzicha JA, Beck Koff P. Exacerbations of COPD. www.ttmed.com
12. Kessler R, Faller M, Fourgault G, Mennecier B, Weitzenblum E (1999) Predictive factors of hospitlization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. AJRCCM 159: 158-164
13. American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic pulmonary diseases. AJRCCM 152: S77-S17
14. Ferguson GT, Enright PL, Buist AS, Higgins MW (2000) Office spirometry for lung health assessment in adults: a consensus statement from the National Health Education Program. Chest 117: 1146-1161
15. Forche G, Stadlober E, Harnoncourt K (1988) Neue spirometrische Bezugswerte für Kinder, Jugendliche und Erwachsene. Ost Arzteztg 43 15/16: 40
16. Niewoehner D, Collins D, Erbland ML (2000) Relation of FEV1 to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. AJRCCM 161: 1201-1205
17. Hermiz O, Comino E, Marks G, Daffurn K, Wilson S, Harris M (2002) Primary care: randomised controlled trial of home based care patients with chronic obstructive disease. BMJ 325: 1-5
18. Vestbo J, Lange P (2002) Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? AJRCCM 166: 329-332
19. Garcia-Aymerich J, Monso E, Marrades R, Escarrabill J, Felez MA, Sunyer J, Anto J (2001) EFRAM Study. Risk factors for hospitalisation for chronic obstructive pulmonary disease exacerbation. AJRCCM 164: 1002-1007
20. Bach P, Brown C, Gelfand SE, McCrory DC (2001) Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 134: 600-620
21. Keenan S, Sinuff T, Cook DJ, Hill NS (2003) Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from noninvasive positiv-pressure ventilation? A systematic review of the literature. Ann Intern Med 138: 861-870
22. Fiore MC et al (2000) Treating tobacco use and dependence. U.S. Department of Health and Humans Services (ISBN 1-58763-007-9)
23. Lacasse Y, et al (2003) Pulmonary rehabilitation for chronic obstructive pulmonary disease. The Cochrane Library, Issue 1, Oxford (update software)